MR contrast injector debuts

Article

Medrad has developed a second-generation injector of MR contrast media. The new product, called Spectris Solaris, will be available worldwide by March. It features enhancements that provide added control and versatility, according to the company. Solaris

Medrad has developed a second-generation injector of MR contrast media. The new product, called Spectris Solaris, will be available worldwide by March. It features enhancements that provide added control and versatility, according to the company. Solaris is compatible with MR scanners ranging from 0.2T to 2T. The company introduced its first-generation Solaris in 1996.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
Related Content
© 2025 MJH Life Sciences

All rights reserved.